(Q37713014)

22 August 2017

1 reference

title

Endocrine profile of ergot alkaloids (English)

1 reference

22 August 2017

0 references

E. E. Můller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202827

3 January 2023

A. E. Panerai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202827

3 January 2023

D. Cocchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202827

3 January 2023

P. Mantegazza

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202827

3 January 2023

language of work or name

English

0 references

publication date

1 December 1977

1 reference

full work available at URL

22 August 2017

https://api.elsevier.com/content/article/PII:0024320577902314?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

https://api.elsevier.com/content/article/PII:0024320577902314?httpAccept=text/plain

3 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

3 January 2023

1 reference

22 August 2017

volume

21

1 reference

22 August 2017

issue

11

1 reference

22 August 2017

page(s)

1545-1558

1 reference

22 August 2017

cites work

Hypothalamic Hormones

1

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Putative neurotransmitters involved in discharging gonadotropin-releasing neurohormones and the action of LH-releasing hormone on the CNS

3 January 2023

2

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Neuropharmacologic control of neuroendocrine function in man

3 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Ergotoxine inhibition of deciduoma formation and its reversal by progesterone

3 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Progesterone reversal of ergotoxine induced suppression of early - pre-implantation - pregnancy

3 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of ergocornine on ovarian synthesis of progesterone and 20 alpha-hydroxy-pregn-4-en-3-one in the pseudopregnant rat

3 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Maintenance of gestation of ergotoxine-treated pregnant rats by exogenous prolactin.

3 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Studies on the mechanism of nidation. XXXI. Failure of ergocornine to interrupt gastation in the rat in the presence of foetal placenta.

3 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effects of Ergocornine on Serum Prolactin and LH, and on Hypothalamic Content of PIF and LRF

3 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effects of ergocornine and 2-Br-α-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice

3 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

[2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat]

3 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effects of 2-Br-α-ergocryptine on plasma prolactin level and milk yield in cows

3 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Treatment of Non-puerperal Galactorrhoea with an Ergot Alkaloid

3 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).

3 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Studies on the Mechanism of the Dopamine-Mediated Inhibition of Prolactin Secretion1

3 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of the Ergot Derivative Lisuride Hydrogen Maleate on Serum Prolactin Concentrations in Female Rats

3 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effects of 2-Br-α-ergokryptine on plasma prolactin level during parturition and onset of lactation in cows

3 January 2023

23

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effects of bromocriptine on milk secretion in the rabbit

3 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

3 January 2023

30

31

1051

Cassell

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancer

3 January 2023

33

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Direct Inhibition by Ergocornine of Pituitary Prolactin Release

3 January 2023

35

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Ergot-induced inhibition of pituitary tumor growth in rats

3 January 2023

36

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study

3 January 2023

38

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

The role of prolactin in the restoration of ovarian function during the early post-partum period in the human female. II. A study during inhibition of lactation by bromergocryptine

3 January 2023

40

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation

3 January 2023

42

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

3 January 2023

44

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Hypothalamic-pituitary function in diverse hyperprolactinemic states

3 January 2023

47

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Hyperprolactinemic anovulatory syndrome

3 January 2023

48

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons.

3 January 2023

49

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Prolactin suppresses release of luteinising hormone during lactation in the monkey

3 January 2023

51

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

A possible role for prolactin in control of steroid secretion by the human Graafian follicle

3 January 2023

52

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Prolactin and testosterone: independent circulating levels in hyperprolactinemic and normoprolactinemic amenorrhea. The effect of prolactin suppression by bromocriptine

3 January 2023

53

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons

3 January 2023

54

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens

3 January 2023

56

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Prolactin inhibition test with L-dopa: decrease and restoration of plasma prolactin levels in the rat by a peripheral process

3 January 2023

57

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of levodopa (L-DOPA) on human hypophyseal tropic hormone release

3 January 2023

59

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

l-DOPA and Pituitary Hormone Secretion

3 January 2023

60

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine

3 January 2023

63

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine

3 January 2023

64

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of L-Dopa on Plasma TSH Levels in Primary Hypothyroidism

3 January 2023

66

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effects of colchicine and 2-Br-alpha-ergocryptine-methane-sulfonate (CB 154) on the release of prolactin and growth hormone by functional pituitary tumor cells in culture

3 January 2023

67

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-α-Ergocryptine

3 January 2023

70

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

The projections of the A8, A9 and A10 dopaminergic cell bodies: evidence for a nigral-hypothalamic-median eminence dopaminergic pathway

3 January 2023

72

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Bromocriptine treatment of acromegaly

3 January 2023

74

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Inhibitory Effect of Dopaminergic Stimulation on GH Release in Acromegaly

3 January 2023

75

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses

3 January 2023

77

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Stimulation of growth hormone release by thyrotropin-releasing hormone in the hypophysectomized rat bearing an ectopic pituitary

3 January 2023

78

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients

3 January 2023

79

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of Five Dopaminergic Drugs on Plasma Growth Hormone Levels in Acromegalic Subjects

3 January 2023

80

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Bromocriptine therapy in acromegaly

3 January 2023

81

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of bromocriptine in pituitary-dependent Cushing's syndrome

3 January 2023

83

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Bromocriptine in Nelson's syndrome and Cushing's disease

3 January 2023

84

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

The effect of ergocornine on melanophores of Ambystoma tigrinum: evidence for suppression of pituitary MSH release

3 January 2023

85

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Ergot alkaloid inhibition of melanophore stimulating hormone secretion

3 January 2023

86

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Biogenic Amines and Control of Melanophore Stimulating Hormone Release

3 January 2023

87

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

3 January 2023

88

35

106

Sweeney

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

The inhibitory effect of an ergoline derivative (lergotrile, compound 83636) on prolactin secretion in man

3 January 2023

89

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients

3 January 2023

90

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Inhibition of Prolactin Secretion by Ergolines

3 January 2023

91

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Inhibition of prolactin secretion by lergotrile mesylate: mechanism of action

3 January 2023

93

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice

3 January 2023

94

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation

3 January 2023

95

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

1-Methyl-8 β-carbobenzyloxy-aminomethyl-10 α-ergoline, a Potent and Long-lasting 5-Hydroxytryptamine Antagonist

3 January 2023

98

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8beta-carbobenzyloxy-aminomethyl-10alpha-ergoline. Interference with amphetamine and DOPA

3 January 2023

99

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors

3 January 2023

100

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Inhibitory role of the serotoninergic system in hypoglycaemia-induced growth hormone release in the dog

3 January 2023

102

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Inhibition of ACTH Response to Oral and Intravenous Metyrapone by Antiserotoninergic Treatment in Man

3 January 2023

103

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

Effect of an Antiserotoninergic Drug, Metergoline, on the ACTH and Cortisol Response to Insulin Hypoglycemia and Lysine-Vasopressin in Man

3 January 2023

104

1 reference

https://api.crossref.org/works/10.1016/0024-3205(77)90231-4

3 January 2023

Identifiers

1 reference

22 August 2017

1 reference